Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

Kohei Tada,Shigehisa Kitano,Hirokazu Shoji,Takashi Nishimura,Yasuhiro Shimada,Kengo Nagashima,Yoshitaka Honma,Satoru Iwasa,Natsuko Okita,Atsuo Takashima,Ken Kato,Yasuhide Yamada,Naoyuki Katayama,Narikazu Boku,Tetsuya Hamaguchi,Yuji Heike

Journal for ImmunoTherapy of Cancer（2015）

引用 1|浏览24

暂无评分

摘要

Meeting abstracts Immunological status in surgically resected specimens affects the outcome of ‘operable’ colorectal cancer patients. For example, a high number of tumor infiltrating lymphocytes, CD3+ cells, CD8+ cells, or CD45RO+ cells in a tumor is associated with improved prognosis. However

查看译文

关键词

Immune Status, Metastatic Colorectal Cancer, Colorectal Cancer Patient, Tumor Infiltrate Lymphocyte, Poor Prognostic Factor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要